liver transplant for biliary atresia: a ten year single ... of liver transplant for... ·...
TRANSCRIPT
Outcomes of Liver Transplant for Biliary Atresia: A Ten Year Single
Centre Experience Dr Yentl van Heerden; Dr Andrew Grieve, Professor Jerome Loveland
For Paediatric Hepatobiliary and Liver Transplant Symposium
University of the Witwatersrand
10-12 November 2017
Introduction
• Biliary Atresia is the most common indication for liver transplantation in the paediatric population1
• 60-80% of patients require liver transplant despite Kasai-portoenterostomy2,3
• Paradox: Earlier on in life (smaller patients, younger patients) with more severe grade of liver dysfunction
1.Esquivel C.O.; Iwatsuki S. et al. (1987) Indications for pediatric liver transplantation. Pediatrics. 111(6): 1039-1045
2.Laurent J, Gauthier F, Bernard O, Hadchouel M, Odivre M, Alagille D (1990) Gastroenterology 99: 1793±179
3.Lopez-Santamaria M, Gamez M, Murcia J, Diez-Pardo J,Diaz M, Leal N, et al. Long-term follow-up of patients with biliary atresia successfully treated with hepatic portoenterostomy.The importance of sequential treatment.Pediatr Surg Int
1998;13:327-330.
University of Witwatersrand – Wits Donald Gordon Medical Centre
Introduction
• Hepatotropic viruses: CMV, EBV, Reo virus – demonstrate poorer outcomes
• Complications: conflicting reports on the complication rates when comparing transplant for biliary atresia vs transplant for other indications
• Enteric complications – universally higher in biliary atresia group.
• Overall survival: Seem to be slightly worse in biliary atresia group, but not statistically significant.
• Cause and timing of death: No correlation between centres.
University of Witwatersrand – Wits Donald Gordon Medical Centre
Introduction
• Factors associated with poorer survival outcomes (generally) • PELD score
• MUAC/Weight of patients
• Era of transplantation
• Experience of centre
• Type of graft used
• BASM/Splenic malformation
University of Witwatersrand – Wits Donald Gordon Medical Centre
Method
• Retrospective Record Review
• WDGPLTU: 2005 – 2016
• Under 18 years
• First liver transplant
• Excluded: Fulminant Hepatic Failure
• Biliary Atresia vs Other Indications • Survival Outcomes
• Factors affecting outcomes
• Complications • Enteric
• Biliary
• Vascular
University of Witwatersrand – Wits Donald Gordon Medical Centre
Data collected
• Age
• Gender
• Race
• Diagnosis
• PELD score
• Previous surgical history (KPE)
• Weight at transplant
• Operation notes (BASM/splenic malformation)
• Complications and treatment of complications
University of Witwatersrand – Wits Donald Gordon Medical Centre
Data collected
• Sources • Patient records
• Lab reports
• Existing database • Redcap (WDGPLTU)
• Ethics (07/09/2017) M170752 HREC Wits
University of Witwatersrand – Wits Donald Gordon Medical Centre
Aims and Objectives
• Overall Aim • To determine if there is a difference between outcomes in patients who have
undergone liver transplant for biliary atresia, compared to patients who have undergone liver transplant for other indications.
• Secondary Aim • To ascertain the factors which determine these outcomes
University of Witwatersrand – Wits Donald Gordon Medical Centre
Aims and Objectives
• Objectives • To analyse 1 year survival outcomes for patients undergoing liver transplant
for biliary atresia vs patients undergoing liver transplant for other indications
• To evaluate the post-operative complications in the group transplanted for biliary atresia vs other
• To distinguish the factors affecting these outcomes
University of Witwatersrand – Wits Donald Gordon Medical Centre
Demographics
• Overall • 101 first time transplants
• 67% female
• 55% black, 35% white, 10% coloured and indian
• Mean Weight: 18.7kg
• Mean Age:5.5y
• Median follow up time: 1.4y
• Biliary atresia • 52 first time transplants
• 67% female
• 63% black, 29% white, 8% other
• Mean weight: 11.2kg
• Mean Age: 2.7y
University of Witwatersrand – Wits Donald Gordon Medical Centre
0 10 20 30 40 50 60
biliary atresia
budd chiari - veno-occlusive disease
auto-immune disease
oxalosis
alpha-1 antitrypsin deficiency
polycystic kidney disease and hepatic fibrosis
alagille syndrome (biliary hypoplasia)
wilson's disease
biliary agenesis
hepatoblastoma
hepatocellular carcinoma
cryptogenic
maple syrup urine disease
PFIC - progressive familial intrahepatic cholestasis
other
% of recpients (n=101)
Indications
Overall Survival
Graft Survival
Complications
Complication
General
Biliary Atresia
Enteric 7% 20%
Biliary 30% 36%
Vascular 12% 10%
University of Witwatersrand – Wits Donald Gordon Medical Centre
Suspected Factors associated with poorer outcomes (interim) • Age
• Gender
• Weight (z-score)
• Mid Upper Arm Circumference (z-score)
• Graft type used
• Transplant era
• Previous Kasai-Portoenterostomy
• PELD Score
• Pre-transplant portal vein thrombosis
• Pre-transplant portal vein hypoplasia
• BASM/Splenic malformation
University of Witwatersrand – Wits Donald Gordon Medical Centre
Causes of Death
0 10 20 30 40 50 60 70
Infection
Graft failure
Cardiopulmonary
Multi-organ failure
PTLD
Recurrent tumour
Haemmorrhage
Other
% of recpients in each group
Biliary atresia Other
0
5
10
15
20
25
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
Nu
mb
er
of
tran
spla
nts
Year of transplant
Conclusions
• No statistical difference in 1 year survival outcomes between the two groups
• Increase in enteric complications in group transplanted for biliary atresia
• -2/-3 Z-score for weight is a proven prognostic factor for poorer overall 1 year survival outcomes
• Living related donor grafts have better graft survival outcomes at 1 year
• The programme continues to gain momentum
Thank you